Robert H. Pierce

22.2k total citations · 1 hit paper
108 papers, 7.4k citations indexed

About

Robert H. Pierce is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Robert H. Pierce has authored 108 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 47 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Robert H. Pierce's work include Cancer Immunotherapy and Biomarkers (20 papers), CAR-T cell therapy research (18 papers) and Immunotherapy and Immune Responses (16 papers). Robert H. Pierce is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), CAR-T cell therapy research (18 papers) and Immunotherapy and Immune Responses (16 papers). Robert H. Pierce collaborates with scholars based in United States, United Kingdom and Japan. Robert H. Pierce's co-authors include Ian Nicholas Crispe, Nelson Fausto, Terrill K. McClanahan, Scott Turner, Leonidas G. Koniaris, Robert A. Kastelein, Jeff Grein, Teresa A. Zimmers, David J. Topham and Edward P. Bowman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nucleic Acids Research.

In The Last Decade

Robert H. Pierce

103 papers receiving 7.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells

2012 791 citations Scott Turner, Cheng‐Chi Chao et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert H. Pierce	3.4k	2.2k	1.8k	988	857	108	7.4k
Mónica Gumá	3.1k 0.9×	1.1k 0.5×	2.5k 1.4×	1.2k 1.3×	1.5k 1.7×	119	7.4k
Pieter Demetter	1.1k 0.3×	2.5k 1.1×	1.8k 1.0×	993 1.0×	606 0.7×	199	6.4k
Mike Salmon	4.7k 1.4×	1.5k 0.7×	2.1k 1.1×	1.1k 1.1×	1.4k 1.6×	80	8.9k
Peter J. Nelson	4.6k 1.3×	3.9k 1.8×	4.8k 2.7×	795 0.8×	779 0.9×	252	13.8k
Saburo Sone	2.2k 0.6×	2.8k 1.3×	3.5k 1.9×	501 0.5×	340 0.4×	259	8.2k
Makoto Naito	2.7k 0.8×	909 0.4×	3.7k 2.1×	878 0.9×	284 0.3×	181	8.3k
Yiwei Chu	3.6k 1.1×	2.4k 1.1×	2.9k 1.6×	641 0.6×	476 0.6×	182	7.7k
Yutaka Sasaki	2.3k 0.7×	1.2k 0.6×	2.6k 1.4×	1.4k 1.4×	240 0.3×	246	7.9k
Antonio Costanzo	3.6k 1.0×	3.5k 1.6×	4.6k 2.5×	1.1k 1.1×	812 0.9×	288	10.7k
Rory R. Koenen	3.6k 1.0×	1.4k 0.6×	2.4k 1.3×	809 0.8×	391 0.5×	108	7.0k

Countries citing papers authored by Robert H. Pierce

Since Specialization

Citations

This map shows the geographic impact of Robert H. Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Pierce more than expected).

Fields of papers citing papers by Robert H. Pierce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Pierce. The network helps show where Robert H. Pierce may publish in the future.

Co-authorship network of co-authors of Robert H. Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Pierce. A scholar is included among the top collaborators of Robert H. Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Pierce. Robert H. Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, F. Donelson, Robert H. Pierce, Thomas Thisted, & Edward H. van der Horst. (2023). Conditionally Active, pH-Sensitive Immunoregulatory Antibodies Targeting VISTA and CTLA-4 Lead an Emerging Class of Cancer Therapeutics. Antibodies. 12(3). 55–55. 5 indexed citations

Voillet, Valentin, Trisha R. Berger, Kelly M. McKenna, et al.. (2022). An In Vivo Model of Human Macrophages in Metastatic Melanoma. The Journal of Immunology. 209(3). 606–620. 7 indexed citations

Church, Candice D., Thomas H. Pulliam, Song Y. Park, et al.. (2022). Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma. Journal for ImmunoTherapy of Cancer. 10(9). e005328–e005328. 14 indexed citations

Andtbacka, Robert H.I., Robert H. Pierce, Jean S. Campbell, et al.. (2022). Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma. Cancer Research Communications. 2(8). 904–913. 15 indexed citations

Schroeder, Brett, Bonnie LaFleur, Rachel Gittelman, et al.. (2021). CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes. Journal for ImmunoTherapy of Cancer. 9(8). e002812–e002812. 25 indexed citations

Horowitz, Lisa F., Kevin W. Bishop, Lindsey A. Barner, et al.. (2020). Microdissected “cuboids” for microfluidic drug testing of intact tissues. Lab on a Chip. 21(1). 122–142. 40 indexed citations

O’Brien, Valerie P., Amanda Koehne, Julien Dubrulle, et al.. (2020). Sustained Helicobacter pylori infection accelerates gastric dysplasia in a mouse model. Life Science Alliance. 4(2). e202000967–e202000967. 7 indexed citations

Ene, Chibawanye, M. Katherine Jung, Huajia Zhang, et al.. (2019). Anti–PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma. Neuro-Oncology. 22(5). 639–651. 42 indexed citations

Seo, Yongwoo David, Xiuyun Jiang, Kevin M. Sullivan, et al.. (2019). Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer. Clinical Cancer Research. 25(13). 3934–3945. 170 indexed citations

10.

Ishida, Eiichi, Jina Lee, Jean S. Campbell, et al.. (2019). Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model. Cancer Immunology Immunotherapy. 68(8). 1273–1286. 7 indexed citations

11.

Kohli, Karan, Yao Lu, Qianchuan He, et al.. (2019). Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial. Cancer Immunology Research. 7(8). 1237–1243. 101 indexed citations

12.

Kargl, Julia, Xiaodong Zhu, Huajia Zhang, et al.. (2019). Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC. JCI Insight. 4(24). 127 indexed citations

13.

Stromnes, Ingunn M., Adam L. Burrack, Ayaka Hulbert, et al.. (2019). Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma. Cancer Immunology Research. 7(6). 977–989. 52 indexed citations

14.

Bhatia, Shailender, Natalie Miller, Rima M. Kulikauskas, et al.. (2019). Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma. Clinical Cancer Research. 26(3). 598–607. 70 indexed citations

15.

Burkart, Christoph, A. Mukhopadhyay, Shawna A. Shirley, et al.. (2018). Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters. Gene Therapy. 25(2). 93–103. 22 indexed citations

16.

Mukhopadhyay, Anandaroop, Jocelyn H. Wright, Shawna A. Shirley, et al.. (2018). Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy. Gene Therapy. 26(1-2). 1–15. 43 indexed citations

17.

Stromnes, Ingunn M., Ayaka Hulbert, Robert H. Pierce, Philip D. Greenberg, & Sunil R. Hingorani. (2017). T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma. Cancer Immunology Research. 5(11). 978–991. 148 indexed citations

18.

Mattox, Austin K., Jina Lee, William H. Westra, et al.. (2017). PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4+ TILs in the Presence of PD-L1+ TAMs. Cancer Research. 77(22). 6365–6374. 76 indexed citations

19.

Adamopoulos, Iannis E., Marlowe S. Tessmer, Cheng‐Chi Chao, et al.. (2011). IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass. The Journal of Immunology. 187(2). 951–959. 158 indexed citations

20.

Kleinschek, Melanie A., Katia Boniface, Svetlana Sadekova, et al.. (2009). Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. The Journal of Experimental Medicine. 206(3). 525–534. 364 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact